Cell line · CVCL_1566
NCI-H520
Cancer cell line, Homo sapiens. Lung squamous cell carcinoma. 56 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. NCI-H520. Cell lines, record CVCL_1566. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1566
On this page
Cell line
As Cellosaurus gives it.
- Name
- NCI-H520
- Accession
- CVCL_1566
- RRID
- RRID:CVCL_1566
- Synonyms
- H520, H-520, NCI-HUT-520, NCIH520
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- Age unspecified
- Category
- Cancer cell line
- Diseases
- Lung squamous cell carcinoma (NCIt C3493)
- Derived from
- Lung (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers56
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Host cell entry and neutralisation sensitivity of H3N2 influenza A virus subclade K. | NPJ Vaccines | 2026 | Its Methods give the RRID and name the line | PubMed | |
| High-throughput ligand discovery in living cells using the cellular protein stability enhancement assay. | Acta Pharm Sin B | 2026 | Its Methods give the RRID and name the line | PubMed | |
| KLF4 Promotes a KRT13+ Hillock-Like State in Lung Squamous Cell Carcinoma. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Activation of GABBR1 by New Ligand Valerate Transcriptionally Regulates ATF4-NRF2-CXCL13 Axis Mediating CD8+ T Cell Anti-Tumor Immunity. | Int J Biol Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| scResponse: A Rank-Based Method for Identifying Cell States That Contribute to Immunotherapy Response by Single-Cell Data. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| C1RL-AS1/microRNA-424-5p/adrenoceptor β2 axis: A novel regulatory mechanism in lung adenocarcinoma associated with immune infiltration and prognosis. | PLoS One | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Macropinocytosis and Vascularization Determine Response to mTOR Inhibitors in Lung Squamous Cell Carcinoma. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Sustained reductions in valine and isoleucine mediate anti-cancer pharmacological effects of inhibiting amino acid transporter LAT1 in cancer cells. | Cancer Metab | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Tobacco Smoking Rewires Cell Metabolism by Inducing GAPDH Succinylation to Promote Lung Cancer Progression. | Cancer Res | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Pan-KRAS Inhibitors BI-2493 and BI-2865 Display Potent Antitumor Activity in Tumors with KRAS Wild-type Allele Amplification. | Mol Cancer Ther | 2025 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 56
See all 56 papersRelatives5
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | EDITGENE NCI-H520-Cas9 | CVCL_F5R1 | Cell lines | |
| Derived from it | EDITGENE NCI-H520-CopGFP | CVCL_F6CU | Cell lines | |
| Derived from it | EDITGENE NCI-H520-FLUC | CVCL_F5VB | Cell lines | |
| Derived from it | HyCyte NCI-H520 KO-hPTPRZ1 | CVCL_E1MA | Cell lines | |
| Derived from it | NCI-H520-EGFP | CVCL_C8X0 | Cell lines |
Cell banks8
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | HTB-182 | ATCC | |
| AddexBio | C0016010/4915 | Cellosaurus | |
| BCRC | 60124 | BCRC | |
| CLS | 305063 | CLS | |
| EDITGENE | EDC00329 | EDITGENE | |
| Hysigen | TCH-C427 | Hysigen | |
| KCB | KCB 2013023YJ | Cellosaurus | |
| Ubigene | YC-C017 | Ubigene |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1566
GET https://conductscience.org/api/cell-lines/v1/CVCL_1566/papers?page=2